Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

Health News

Study Funded By The United States Potato Board Shows That Potatoes Provide One Of The Best Nutritional Values Per Penny

Date: May-28-2013
A frequently expressed concern in the ongoing public health debate is the lack of affordability of fresh vegetables, especially those that are nutrient dense. A new study, "Vegetable Cost Metrics Show That Potatoes and Beans Provide Most Nutrients Per Penny," published in the journal PLOS ONE, shows that potatoes are one of the best nutritional values in the produce aisle, providing one of the better nutritional values per penny than most other raw vegetables and delivering one of the most affordable source of potassium of the more frequently consumed vegetables, second only to beans. Dr...

Alcohol Placements In Movies On The Rise

Date: May-28-2013
A recent study which carried out a thorough analysis of top box-office movies in the U.S. found that although tobacco brand placements have significantly dropped, the number of alcohol placements has been steadily rising in movies rated acceptable for youth audiences. The Master Settlement Agreement (MSA), which was entered in November 1998, required most tobacco brand manufacturers not to "take any action, directly or indirectly, to target Youth". Since this settlement the number of tobacco brand placements has declined...

Heart Failure Patients Admitted In January, On Friday, And Overnight At Highest Risk Of Mortality

Date: May-28-2013
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented at the Heart Failure Congress 2013. The analysis of nearly 1 million heart failure admissions over 14 years was presented by Dr David P. Kao (Denver, Colorado). The Heart Failure Congress 2013 is taking place during 25-28 May in Lisbon, Portugal. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology...

Coenzyme Q10 - First Drug To Improve Heart Failure Mortality In Over A Decade

Date: May-28-2013
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality in over a decade and should be added to standard treatment, according to lead author Professor Svend Aage Mortensen (Copenhagen, Denmark). Heart Failure 2013 is being held from 25-28 May in Lisbon, Portugal. It is the main annual meeting of the Heart Failure Association of the European Society of Cardiology...

Genomic Analysis Lends Insight Into Prostate Cancer

Date: May-28-2013
Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings appear online in the journal Cancer Research. "This is the first study to examine DNA alterations using next generation sequencing in adjacent Gleason patterns in the same tumor allowing us to correlate genomics with changes in pathology," says John Cheville, M.D., Mayo Clinic pathologist and one of the authors on the paper...

How Rapamycin Slows Cell Growth

Date: May-28-2013
University of Montreal researchers have discovered a novel molecular mechanism that can potentially slow the progression of some cancers and other diseases of abnormal growth. In the prestigious journal Cell, scientists from the University of Montreal explain how they found that the anti-cancer and anti-proliferative drug rapamycin slows down or prevents cells from dividing. "Cells normally monitor the availability of nutrients and will slow down or accelerate their growth and division accordingly...

Statistically Significant Reduction In Death Of Advanced Heart Failure Patients, But Outcomes Are Still Not Ideal

Date: May-28-2013
UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden cardiac death, caused by the rapid onset of severe abnormal heart rhythms, has declined. However, the team found that even today, with these significant improvements, one-third of patients don't survive more than three years after being diagnosed with advanced disease...

Discovery Made In Fish Could Aid Research Into Motor Neuron Disease

Date: May-28-2013
Scientists have found that a key hormone allows young zebrafish to develop and replace their motor neurons - a kind of nerve cell found in the spinal cord. The discovery may aid efforts to create neurons from stem cells in the lab, and support further research into a disorder for which there is still no cure. In humans, motor neurons control important muscle activities such as speaking, walking and breathing. When these cells stop working, it causes difficulties in motor functions and leads to paralysis and death...

Therapy Now Being Tested In Advanced Cancer Could Halt Progression Of Premalignant Cells

Date: May-28-2013
Scientists have uncovered a survival mechanism that occurs in breast cells that have just turned premalignant-cells on the cusp between normalcy and cancers-which may lead to new methods of stopping tumors. In their Molecular Cell study, the Salk Institute researchers report that a protein known as transforming growth factor beta (TGF-β), considered a tumor suppressor in early cancer development, can actually promote cancer once a cell drifts into a pre-cancerous state...

In States With Helmet Laws, Bicycle-Related Fatalities Significantly Lower

Date: May-28-2013
Existing research shows that bicyclists who wear helmets have an 88 percent lower risk of brain injury, but researchers at Boston Children's Hospital found that simply having bicycle helmet laws in place showed a 20 percent decrease in deaths and injuries for children younger than 16 who were in bicycle-motor vehicle collisions. The cross-sectional study, conducted by William P. Meehan III, MD, Lois K. Lee, MD, MPH, Rebekah C. Mannix, MD, MPH of Boston Children's Hospital, and Christopher M...